Charles Schwab Investment Management Inc Dare Bioscience, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 30,532 shares of DARE stock, worth $10,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,532
Previous 30,532
-0.0%
Holding current value
$10,380
Previous $9,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DARE
# of Institutions
37Shares Held
6.86MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.45MShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$336,3640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$259,3860.0% of portfolio
-
Black Rock Inc. New York, NY396KShares$134,6730.0% of portfolio
-
State Street Corp Boston, MA248KShares$84,2210.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $28.8M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...